Discussion: session 2

Future Oncol. 2013 Dec;9(12 Suppl):37-9. doi: 10.2217/fon.13.202.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents